Kerry Holford

Stock Analyst at Berenberg

(2.42)

# 2,523

Out of 4,996 analysts

10

Total ratings

57.14%

Success rate

12.94%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Kerry Holford

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Upgrades: Buy	n/a	$55.61	-	1	Sep 17, 2025
	LLY Eli Lilly and Company	Downgrades: Hold	$970 → $830	$724.54	+14.56%	9	Sep 17, 2025

Novo Nordisk

Sep 17, 2025

Upgrades: Buy

Price Target: n/a

Current: $55.61

Upside: -

Eli Lilly and Company

Sep 17, 2025

Downgrades: Hold

Price Target: $970 → $830

Current: $724.54

Upside: +14.56%